[Determination of drug concentrations in body fluid; possibilities and limitations. II. Determination of plasma levels as a part of individual patient treatment].
D000319:Adrenergic beta-Antagonists / Q000097:blood; D000889:Anti-Arrhythmia Agents / Q000097:blood; D000890:Anti-Infective Agents / Q000097:blood; D000893:Anti-Inflammatory Agents / Q000097:blood; D000927:Anticonvulsants / Q000097:blood; D000928:Antidepressive Agents / Q000097:blood; D000959:Antihypertensive Agents / Q000097:blood; D000970:Antineoplastic Agents / Q000097:blood; D014150:Antipsychotic Agents / Q000097:blood; D002301:Cardiac Glycosides / Q000097:blood; D004358:Drug Therapy / Q000592:standards*; D006801:Humans; D004364:Pharmaceutical Preparations / Q000097:blood*; D013806:Theophylline / Q000031:analogs & derivatives; D014149:Tranquilizing Agents / Q000097:blood
D000319:Adrenergic beta-Antagonists; D000889:Anti-Arrhythmia Agents; D000890:Anti-Infective Agents; D000893:Anti-Inflammatory Agents; D000927:Anticonvulsants; D000928:Antidepressive Agents; D000959:Antihypertensive Agents; D000970:Antineoplastic Agents; D014150:Antipsychotic Agents; D002301:Cardiac Glycosides; D004364:Pharmaceutical Preparations; D014149:Tranquilizing Agents; D013806:Theophylline
Bepaling van geneesmiddelconcentraties in lichaamsvloeistoffen; mogelijkheden en beperkingen. II. Bepaling van plasmaspiegels als onderdeel van de behandeling van de individuele patiënt.